{"id":40204,"date":"2012-04-09T00:00:00","date_gmt":"2012-04-09T05:00:00","guid":{"rendered":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/"},"modified":"2022-08-22T16:19:20","modified_gmt":"2022-08-22T21:19:20","slug":"breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/","title":{"rendered":"Breakthrough drug brings new hope for cystic fibrosis patients"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\"><p dir=\"ltr\">\n<b><i><font face=\"Times New Roman\">National CF leader, Dr. Robert Beall, is coming to Omaha April 13-14<\/font><\/i><\/b><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">For patients with cystic fibrosis, the future has never looked brighter.<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">About two months ago, the <\/font><a href=\"http:\/\/www.fda.gov\/\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">Food and Drug Administration<\/font><\/font><\/u><\/a><font face=\"Times New Roman\"> approved a new drug for CF patients known as <\/font><a href=\"http:\/\/www.kalydeco.com\/\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">Kalydeco<\/font><\/font><\/u><\/a><font face=\"Times New Roman\"> (kuh-LYE-deh-koh).<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">For about 4 percent of the CF population &ndash; those ages 6 and older with the G551D mutation of cystic fibrosis &ndash; the drug represents an important breakthrough. Taken in pill form, the drug dramatically improves lung function, lowers sweat chloride levels and helps patients gain weight &ndash; all key clinical indicators of CF.<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">&ldquo;Kalydeco addresses the underlying cause of CF,&rdquo; said <\/font><a href=\"http:\/\/www.cff.org\/aboutCFFoundation\/PresidentMessage\/\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">Robert Beall, Ph.D.<\/font><\/font><\/u><\/a><font face=\"Times New Roman\">, president and CEO of the <\/font><a href=\"http:\/\/www.cff.org\/\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">Cystic Fibrosis Foundation<\/font><\/font><\/u><\/a><font face=\"Times New Roman\">. &ldquo;The science behind the drug has opened exciting new doors to research and development that may eventually lead to additional therapies that will benefit more people living with CF.&rdquo;<\/font><font face=\"Calibri\" size=\"3\"><font face=\"Calibri\" size=\"3\"> <\/font><\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">For Barry Zoob, chairman emeritus of the <\/font><a href=\"http:\/\/www.cff.org\/Chapters\/nebraska\/\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">Nebraska Chapter of the Cystic Fibrosis Foundation<\/font><\/font><\/u><\/a><font face=\"Times New Roman\"> and a board member for 35 years, the discovery of Kalydeco is a true milestone.<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">&ldquo;For the first time in history, we have found a path where young people can live with the disease rather than die from it,&rdquo; Zoob said. &ldquo;Kalydeco could be as significant for CF patients as the discovery of insulin was for people with diabetes.&rdquo;<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">Dr. Beall has been a driving force in the progress being made in CF treatments, said <\/font><a href=\"http:\/\/www.unmc.edu\/pediatrics\/colombo_john.htm\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">John Colombo, M.D.<\/font><\/font><\/u><\/a><font face=\"Times New Roman\">, professor, pediatrics pulmonology, and director of the cystic fibrosis program at the <\/font><a href=\"http:\/\/www.unmc.edu\/\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">University of Nebraska Medical Center<\/font><\/font><\/u><\/a><font face=\"Times New Roman\"> and <\/font><a href=\"http:\/\/childrensomaha.org\/\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">Children&rsquo;s Hospital &amp; Medical Center<\/font><\/font><\/u><\/a><font face=\"Times New Roman\">.<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">&ldquo;Dr. Beall pulls the strings for everything in CF,&rdquo; Dr. Colombo said. &ldquo;He has an amazing mind. He&rsquo;s the guy behind the basic science who has been able to get the scientists together.&rdquo;<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">Dr. Beall will be coming to Omaha on April 13-14. He will meet with UNMC&rsquo;s CF team and members of the Nebraska Cystic Fibrosis Foundation Chapter on Friday and will be a presenter at a CF Conference at UNMC&rsquo;s Durham Research Center on Saturday. <\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">&ldquo;CF treatment is evolving,&rdquo; Dr. Colombo said. &ldquo;About eight years ago, we all thought gene therapy was the answer, but it didn&rsquo;t pan out. Now it&rsquo;s protein manipulation. We can manipulate the protein and control the disease. It&rsquo;s an exciting time for CF. We have new studies coming up that will involve younger kids with different mutations.&rdquo;<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">The vast majority of individuals with CF in the United States &ndash; nearly 90 percent &ndash; have a mutation called <\/font><a href=\"http:\/\/www.ornl.gov\/sci\/techresources\/Human_Genome\/posters\/chromosome\/cftr.shtml\"><u><font color=\"#0000ff\" face=\"Times New Roman\"><font color=\"#0000ff\" face=\"Times New Roman\">Delta F508<\/font><\/font><\/u><\/a><font face=\"Times New Roman\">, Dr. Colombo said.<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">Developing therapies for patients with the Delta F508 mutation is among the current research priorities of the CF Foundation. Progress toward this goal includes an ongoing Phase 2 clinical trial of Kalydeco in combination with another potential therapy, VX-809, in people with the Delta F508 mutation. <\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">Results from the first part of this Phase 2 trial were positive. The second part of the study is now under way.<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide). A defective gene and its protein product cause the body to produce unusually thick, sticky mucus that:<\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Symbol\">&middot; <\/font><font face=\"Times New Roman\">clogs the lungs and leads to life-threatening lung infections; and <\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Symbol\">&middot; <\/font><font face=\"Times New Roman\">obstructs the pancreas and stops natural enzymes from helping the body break down and absorb food. <\/font><\/p>\n<p dir=\"ltr\">\n<font face=\"Times New Roman\">In the 1950s, few children with cystic fibrosis lived to attend elementary school. Today, advances in research and medical treatments have further enhanced and extended life for children and adults with CF. Many people with the disease can now expect to live into their 30s, 40s and beyond.<\/font><\/p>\n<p>\n<i><font face=\"Times New Roman\" size=\"2\"><font face=\"Times New Roman\" size=\"2\">Through world-class research and patient care, UNMC generates breakthroughs that make life better for people throughout Nebraska and beyond. Its education programs train more health professionals than any other institution in the state. Learn more at unmc.edu.<\/font><\/font><\/i><\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>National CF leader, Dr. Robert Beall, is coming to Omaha April 13-14 For patients with cystic fibrosis, the future has never looked brighter. About two months ago, the Food and Drug Administration approved a new drug for CF patients known as Kalydeco (kuh-LYE-deh-koh). For about 4 percent of the CF population &ndash; those ages 6 [&hellip;]<\/p>\n","protected":false},"author":78,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-40204","post","type-post","status-publish","format-standard","hentry","category-uncategorized","topic-patient-care","department-college-of-medicine","department-internal-medicine","department-pediatrics","department-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Breakthrough drug brings new hope for cystic fibrosis patients<\/title>\n<meta name=\"description\" content=\"National CF leader, Dr. Robert Beall, is coming to Omaha April 13-14 For patients with cystic fibrosis, the future has never looked brighter. About two\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breakthrough drug brings new hope for cystic fibrosis patients\" \/>\n<meta property=\"og:description\" content=\"National CF leader, Dr. Robert Beall, is coming to Omaha April 13-14 For patients with cystic fibrosis, the future has never looked brighter. About two\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Newsroom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/unmcedu\" \/>\n<meta property=\"article:published_time\" content=\"2012-04-09T05:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-22T21:19:20+00:00\" \/>\n<meta name=\"author\" content=\"Tom O&#039;Connor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@unmc\" \/>\n<meta name=\"twitter:site\" content=\"@unmc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tom O&#039;Connor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/\"},\"author\":{\"name\":\"Tom O'Connor\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/8171e6fec87d2b600ff48511fa418536\"},\"headline\":\"Breakthrough drug brings new hope for cystic fibrosis patients\",\"datePublished\":\"2012-04-09T05:00:00+00:00\",\"dateModified\":\"2022-08-22T21:19:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/\"},\"wordCount\":678,\"publisher\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/\",\"name\":\"Breakthrough drug brings new hope for cystic fibrosis patients\",\"isPartOf\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#website\"},\"datePublished\":\"2012-04-09T05:00:00+00:00\",\"dateModified\":\"2022-08-22T21:19:20+00:00\",\"description\":\"National CF leader, Dr. Robert Beall, is coming to Omaha April 13-14 For patients with cystic fibrosis, the future has never looked brighter. About two\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unmc.edu\/newsroom\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breakthrough drug brings new hope for cystic fibrosis patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#website\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/\",\"name\":\"Newsroom\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\",\"name\":\"University of Nebraska Medical Center\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png\",\"contentUrl\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png\",\"width\":500,\"height\":153,\"caption\":\"University of Nebraska Medical Center\"},\"image\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/unmcedu\",\"https:\/\/x.com\/unmc\",\"https:\/\/instagram.com\/iamunmc\",\"https:\/\/www.youtube.com\/user\/UNMCEDU\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/8171e6fec87d2b600ff48511fa418536\",\"name\":\"Tom O'Connor\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/author\/35f4a8d465e6e1edc05f3d8ab658c551\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Breakthrough drug brings new hope for cystic fibrosis patients","description":"National CF leader, Dr. Robert Beall, is coming to Omaha April 13-14 For patients with cystic fibrosis, the future has never looked brighter. About two","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/","og_locale":"en_US","og_type":"article","og_title":"Breakthrough drug brings new hope for cystic fibrosis patients","og_description":"National CF leader, Dr. Robert Beall, is coming to Omaha April 13-14 For patients with cystic fibrosis, the future has never looked brighter. About two","og_url":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/","og_site_name":"Newsroom","article_publisher":"https:\/\/www.facebook.com\/unmcedu","article_published_time":"2012-04-09T05:00:00+00:00","article_modified_time":"2022-08-22T21:19:20+00:00","author":"Tom O'Connor","twitter_card":"summary_large_image","twitter_creator":"@unmc","twitter_site":"@unmc","twitter_misc":{"Written by":"Tom O'Connor","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/#article","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/"},"author":{"name":"Tom O'Connor","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/8171e6fec87d2b600ff48511fa418536"},"headline":"Breakthrough drug brings new hope for cystic fibrosis patients","datePublished":"2012-04-09T05:00:00+00:00","dateModified":"2022-08-22T21:19:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/"},"wordCount":678,"publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/","url":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/","name":"Breakthrough drug brings new hope for cystic fibrosis patients","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#website"},"datePublished":"2012-04-09T05:00:00+00:00","dateModified":"2022-08-22T21:19:20+00:00","description":"National CF leader, Dr. Robert Beall, is coming to Omaha April 13-14 For patients with cystic fibrosis, the future has never looked brighter. About two","breadcrumb":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.unmc.edu\/newsroom\/2012\/04\/09\/breakthrough-drug-brings-new-hope-for-cystic-fibrosis-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unmc.edu\/newsroom\/"},{"@type":"ListItem","position":2,"name":"Breakthrough drug brings new hope for cystic fibrosis patients"}]},{"@type":"WebSite","@id":"https:\/\/www.unmc.edu\/newsroom\/#website","url":"https:\/\/www.unmc.edu\/newsroom\/","name":"Newsroom","description":"","publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.unmc.edu\/newsroom\/#organization","name":"University of Nebraska Medical Center","url":"https:\/\/www.unmc.edu\/newsroom\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/","url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","contentUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","width":500,"height":153,"caption":"University of Nebraska Medical Center"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/unmcedu","https:\/\/x.com\/unmc","https:\/\/instagram.com\/iamunmc","https:\/\/www.youtube.com\/user\/UNMCEDU"]},{"@type":"Person","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/8171e6fec87d2b600ff48511fa418536","name":"Tom O'Connor","url":"https:\/\/www.unmc.edu\/newsroom\/author\/35f4a8d465e6e1edc05f3d8ab658c551\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/40204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/users\/78"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/comments?post=40204"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/40204\/revisions"}],"predecessor-version":[{"id":74431,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/40204\/revisions\/74431"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/media?parent=40204"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/categories?post=40204"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/tags?post=40204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}